EUTM file information
019058384
ANELLOVECTOR
July 22, 2024
Trademark Summary
The trademark application ANELLOVECTOR was filed by Ring Therapeutics, Inc., a U.S. corporation (the "Applicant"). Registered.
The application was filed in English (German was selected as the second language).
Goods And Services
- The mark was filed in class 5 with following description of goods:
- Encapsulated nucleic acid agents for medical use
- Pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/auto inflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
- Pharmaceutical preparations for use in gene therapy.